A Clinicopathological Study of Mucocutaneous Lesions in Correlation with CD4 Counts in HIV Seropositive Cases at a Tertiary Care Centre in South India
Main Article Content
Abstract
Background: Mucocutaneous lesions are one of the first clinical presentations of immunosuppression in Human Immunodeficiency Virus (HIV) seropositive patients that manifest at different stages of the infection that requires early diagnosis along with prompt treatment(1).
Objectives: (1) To study the prevalence of mucocutaneous manifestations in HIV‑seropositive patients attending the ART center of our hospital in Visakhapatnam, Andhra Pradesh. (2) To correlate mucocutaneous manifestations with CD4 cell counts.
Materials and methods: 150 HIV positive patients above 18 year old with definite cutaneous manifestations attending ART center and OPD in the Department of Dermatology and venereology in a tertiary care centre Visakhapatnam (Andhra Pradesh, India) were studied from May 2020 to May 2021.
Results: Out of 150 HIV patients, who aged 20 -80 years with a mean age of 25, (23.8%) were 60 (40%) female and 90 (60%) were males, majority of the patients were labourers 50 (33.3%) by occupation , 41 (27.3%) had CD4 counts < 200, 73 (48.6%) had CD4 counts of 200–500, and 54 (36%) had CD4 counts > 500. The most common dermatological presentation was pruritic papular eruptions 24 (16.%) followed by cutaneous drug reaction 19(12.67%) and scabies 12 (8%).
Conclusion: At the end of study we concluded that cutaneous manifestations can be considered as good clinical indicators for the progression of disease and underlying immune status in resource poor settings
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Oninla OA. Mucocutaneous manifestations of HIV and the correlation with WHO clinical staging in a tertiary hospital in Nigeria. AIDS Res Treat 2014;2014:360970
Estimated Adult HIV Prevalence, State-wise, India, 2017 HIV Sentinel Surveillance and HIV Estimation, 2017. National AIDS Control Organization (NACO), India
Kanmani CI, Udayashankar C, Nath AK. Dermatology life quality index in patients infected with HIV: A comparative study. Egypt Dermatol Online J 2013;9:3
Bjekić M, Šipetić S. Skin diseases and sexually transmitted infections among patients with HIV infection/AIDS referred at the city institute for skin and venereal diseases in belgrade: A case series of 38 patients. Serbian J Dermatol Venerol 2013;5:125-3
Tripathy S. Classification and staging of HIV disease. In: Vinay Kulkarni, Prayas (eds). HIV/AIDS: Diagnosis and Management. 1st edition. 1999: 85-96.
F. C. Laurent, M. G. Flores, N. Mendez et al., “New insightsinto HIV-1-primary skin disorders,” Journal of the International AIDS Society, vol. 14, p. 5, 2011.
Schwartzman W, Lambertus MW, Kennedy CA, Goetz MB. Staphylococcal pyomyositis in patients infected by HIV. Am J Med. 1991;90:595-600.
Sharma YK, Sawhney MPS, Bhakuni DS, Gera V. Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting. MJAFI. 2004;60:239-43.
Neeti Kumari, Kewal Krishan, Jatinder Singh Bist, Anil Kumar Mehta Study of cutaneous manifestation of HIV disease in correlation with CD4 lymphocyte countInternational Journal of Research in Dermatology DOI:
http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20193234
Mina Mirnezami,1 Nader Zarinfar,2 Masoomeh Sofian,3 Bahareh Botlani Yadegar,3 and Hoda Rahimi Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts Hindawi Scientifica Volume 2020, Article ID 3756,4 page
https://doi.org/10.1155/2020/7503756
Kumarswamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP, Yesudian P. Dermatologic manifestations among HIV patients in South India. Int J Dermatol. 2000;39:192-5.
Raju PV, Rao GR, Ramani TV, Vandana S. Skin disease: Clinical indicator of immune status in HIV infection. Int J Dermatol. 2005;44:646-49
S.mith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1 positive patients: a 42 month prospective study. J Am Acad Dermatol. 1994;31:746.
Bhandary PG, Kamath NK, Pai GS, Rao G. Cutaneous manifestations of HIV infection. Indian J Dermatol Venereol Leprol. 1997;63:35-7.
Singh A, Thappa MD, Hamide A. The spectrum of mucocutaneous manifestations during the evolutionary phases of HIV disease: an emerging Indian scenario. J Dermatol. 1999;26(5):294-304.
Chacko S, John TJ, Babu PG, Jacob M, Kaur A, Mathai D. Clinical profile of AIDS in India: a review of 61 cases. J Associ Phys India. 1995;43(8):535-8.
Liautaud B, Pape JW, DeHovitz JA, Thomas F, LaRoche AC, Verdier RI, et al. Pruritic skin lesions: A common initial presentation of AIDS. Arch Dermatol. 1989;125:629-32.
Goldstein B, Berman B, Sukenik E, Frankel SJ. Correlation of skin disorders with CD4 lymphocyte counts in patient with HIV/AIDS. J Am Acad Dermatol. 1997;36(2):262-4.
S. Lowe, R. A. Ferrand, R. Morris-Jones et al., “Skin disease among Human Immunodeficiency Virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection,”-e Pediatric Infectious Disease Journal, vol. 29, no. 4,pp. 346–351, 2010.
R. F. Dwiyana, R. Rowawi, M. Lestari et al., “Skin disorders in HIV-infected patients from west java,” Acta Med Indones,vol. 41, pp. 18–22, 2009.
B. Muhammad, L. Eligius, F. Mugusi et al., “)e prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in dar es salaam,” Tropical Doctor,vol. 33, no. 1, pp. 44–48, 2003.
Lienhardt C, Kamate B, Jamet P, Tounkara A, Faye OC, Sow SO et al. Effect of HIV infection on leprosy: a three year survey in Bamako Mali. Int J Lepr other Mycobact Dis. 1996;64(4):383-91.